Personal tools
You are here: Home BioBusiness Success stories NKI III
Document Actions

NKI III

RNA interference in mammalian cells

The use of RNA interference in mammalian cells to identify loss-of-function phenotypes is possible using short double-stranded RNA molecules (siRNAs), which are limited by the transient inhibition of gene expression and their high cost. We have developed expression vectors that direct the synthesis of short hairpin RNAs (shRNAs) which are processed in vivo to siRNA-like molecules that can suppress gene expression over prolonged periods of time. We have constructed large sets of retroviral vectors which target thousands of genes for suppression. These RNA interference libraries are applied in cell-based functional screens in order to unravel molecular pathways associated with cancer, which can lead to the identification of novel drug targets in disease.

clmn_image

It’s business stupid

What is it with the Dutch that they have such difficulty grabbing business opportunities in a changing world? We have the brains, we have the money and the opportunities are plenty. Still, during the last 40 years hardly any company of substantial size has emerged next to the old industry in the AEX.  Oil, food, materials and financial services dominate the landscape.

We have left the environmental challenges to environmentalists, rather then building innovative businesses in solar or wind energy to help face them. We have exported our knowledge on agriculture around the world, and now that we can more intelligently engineer crops we let the opportunity pass due to invalid arguments around GMOs. Now that  “kweekersrecht” is being substituted by patent law we complain instead of adapt.

Continue

 

Powered by Plone CMS, the Open Source Content Management System

This site conforms to the following standards: